Kunobva: yaozhi.com
Nhanganyaya: zvinoenderana nedata rekiriniki razvino, molnupiravir inogona kungodzikisa huwandu hwekurapwa kana kufa ne30%.
Musi waMbudzi 30, pane FDA yakavhota na13:10 kubvumidza chikumbiro cheEUA chemolnupiravir, mushonga mutsva wekunwa weMSD.Kana zvikabvumidzwa, chero paine gwaro rachiremba, varwere vakasimbiswa kana vanhu vakafumurwa nehutachiona vanogona kushandisa mushonga uyu kumba vasina kuenda kuchipatara kana kukiriniki kunorapwa senge monoclonal antibody drug.
MSD 111.png
Molnupiravir mushonga mutsva wekorona wakagadzirwa nemosadon mukubatana nekambani yeRidgeback biotherapy.Yakambowana mvumo yekushandiswa kwekukurumidzira muUK, asi ichangoburwa yakaburitswa data yekiriniki inoratidza kuti chiyero chinoshanda chadzikira zvakanyanya.
Sekureva kwechiziviso cheMSD svondo rapfuura, mhinduro dzekupedzisira dzakaratidza kuti vanhu makumi matanhatu nevasere vari muboka rema699 placebo vakaiswa muchipatara kana kufa, nepo makumi mana nevasere chete pavarwere mazana manomwe nenomwe vaitora monapiravir vakawedzera kuderera, izvo zvakaderedza njodzi yekuiswa muchipatara / kufa kubva pa9. 6.8%, uye chiyero chekudzikisa njodzi chakasvika 30%.Zvakakosha kutaura kuti vanhu vapfumbamwe vakafa muboka replacebo uye mumwe chete muboka remolnupiravir.
Zvakadaro, komiti yeUS FDA nyanzvi yakavhota gumi nematatu kusvika gumi kutsigira molnupiravir, mushonga unorwisa hutachiona hwemethadone, ichiti mabhenefiti anodarika njodzi.FDA haisungirwe kutevedzera zvinokurudzirwa nekomiti, asi kazhinji inosarudza kuzvitevera.
Pamusoro pezvo, Pfizer iri kutsvagawo mvumo yeFDA yemushonga wayo mutsva wekorona.Chikamu chechitatu chekiriniki yekuongorora paxlovid, korona itsva yemukanwa mushonga, inoratidza kuti njodzi yekuiswa muchipatara kana kufa inogona kuderedzwa ne89% muvarwere vane hunyoro kusvika pakati nepakati korona itsva mukati memazuva matatu ekuongororwa, izvo zvinofananidzwa nemhedzisiro yekurapa. yekumisa antibody yekorona itsva.
Responsible editor: Liuli
Nguva yekutumira: Zvita-02-2021